Metabolic Complications Cardiovascular Disease / Cholesterol Triglycerides / Diabetes / Insulin Resistance / Hyperlipidemia / Myocardial Infarction
Effective Antiretroviral Therapy Leads to Improved Lung Function in People with HIV 10/09/09 HIV Infection Sharply Increases Risk of Atherosclerosis, but Antiretroviral Therapy Has a Minor Effect 9/11/09 Artery Elasticity Is Reduced in People with Untreated HIV Infection 9/11/09 Confounding Factors May Explain Elevated Cardiovascular Risk in Patients Taking Abacavir 7/28/09 Nevirapine (Viramune) Has Equal Efficacy but a More Favorable Lipid Profile Compared with Boosted Atazanavir (Reyataz) 7/28/09 Intensive Cardiovascular Intervention Lowers Blood Lipids in HIV Patients on Antiretroviral Therapy 7/24/09 Switching from Lopinavir/ritonavir (Kaletra) to Boosted Atazanavir (Reyataz) Reduces Visceral Fat and Improves Glucose Metabolism 7/10/09 Ongoing HIV Replication during Treatment Interruption Is Associated with Inflammatory and Cardiovascular Risk Markers 6/5/09 GlaxoSmithKline Meta-analysis Does Not Show Elevated Cardiovascular Risk Associated with Use of abacavir (Ziagen, Epzicom) 5/19/09 Metabolic and Body Shape Abnormalities Are Common in Children and Youth with HIV 5/15/09 Natural Hormone Leptin Improves Blood Lipid Levels and Insulin Sensitivity and Decreases Abdominal Fat in People with HIV 5/08/09 Study Shows High Prevalence of Metabolic Syndrome and Associated Cardiovascular Risk in Older HIV Patients 1/13/09 Ezetimibe (Zetia) Reduces Bad LDL Cholesterol in HIV Positive People on HAART 10/17/08 Blood Lipid Profiles Improve after CD4-guided Treatment Interruption 9/25/08 SMART Researchers Publish Findings Showing Abacavir (Ziagen) Is Associated with Elevated Risk of Cardiovascular Disease 9/09/2008 Management of Elevated Blood Lipids May Be Less Successful in HIV Patients with High Cardiovascular Risk 9/09/2008 Does Raltegravir (Isentress) Worsen Depression in HIV Patients with a History of Treatment for Depression? 9/05/08 Levels of Osteopontin Protein Are Elevated in People with HIV-associated Dementia 9/05/08 FDA Announces Changes to Ritonavir (Norvir) Label to Reflect New Data on Heart Rhythm Abnormalities 9/05/08 Coronary Heart Disease, HIV Infection, and Antiretroviral Therapy 8/22/08 Studies Look at Association between CD4 Cell Count and Cardiovascular Risk in People with HIV 8/22/08 Does Abacavir (Ziagen) Raise Heart Attack Risk? Conflicting Answers from SMART and 54-study Pooled Analysis 8/12/08 Does Abacavir (Ziagen) Raise Heart Attack Risk? Conflicting Answers from SMART and 54-study Pooled Analysis 8/12/08 Experts Recommend Cardiovascular Risk Screening for People with HIV 7/08/08 HIV Positive Children and Adolescents Have Elevated Risk of Cardiovascular Disease 7/08/08 Studies Find Minimal Cardiovascular Benefit and Increased Mortality with Intensive Glucose Management for People with Type 2 Diabetes 6/20/08 High-density Lipoprotein (HDL) Cholesterol in People with HIV: Association with Viral Load and Antiretroviral Therapy 6/03/08 Ezetimibe Combined with Low-dose Statin Drugs Effectively Reduces Low Density Lipoprotein (LDL) in HIV Patients on Protease Inhibitors 6/03/08 Controlling Cholesterol with Statins 5/23/08 Does Tenofovir (Viread) Increase Liver Toxicity Related to Efavirenz (Sustiva)? 5/16/08 Body Fat and Blood Lipid Levels in Men and Women with HIV 5/16/08 Body Shape Changes in HIV Positive and HIV Negative Women 5/16/08
Worsening Cardiovascular Risk among HIV Positive Individuals in D:A:D Study Has Not Led to an Increase in Heart Attacks 5/13/08 Interaction between Lopinavir-ritonavir (Kaletra) and Rosuvastatin (Crestor) Reduces Drug's Lipid-lowering Effect 5/13/08 Persistent AIDS-related Kaposi Sarcoma in the HAART Era Reveals Need for New Therapies 5/09/08 Large Study Finds Several Types of Non-AIDS-defining Cancer Are More Common in HIV Positive People 5/30/08 Interrupting Antiretroviral Therapy Does Not Reduce the Risk of Cardiovascular Disease: Final Results of ACTG 5102 4/29/08
Fish Oil with or without Fenofibrate Reduces Elevated Triglycerides in HIV Patients on HAART 4/18/08 Elevated Fibrinogen Levels Linked to Protease Inhibitors May Contribute to Elevated Cardiovascular Risk 4/15/08 Protease Inhibitors Linked to Elevated Cholesterol in HIV-infected Children 4/04/08
